Verastem Oncology (VSTM) Misses Q1 EPS by 79c

Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.79).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Freedom Broker Downgrades Nucor (NUE) to Hold, 'Guides Conservative Earnings Yet Again'
• EMA panel backs Novartis Cosentyx for rheumatic condition in EU
• Newsom Issues Executive Order On Creation Of Ai 'kill Switch' - Bloomberg